醫(yī)療特長(zhǎng)（限400字內(nèi)）：
在胸部腫瘤（肺癌,，乳腺癌，食管癌）,，腹部腫瘤（胃癌,，腸癌），頭頸部癌等腫瘤綜合治療方面積累了豐富的臨床經(jīng)驗(yàn)和科研基礎(chǔ),。擅長(zhǎng)泌尿系統(tǒng)腫瘤（膀胱,、前列腺、腎臟腫瘤）,，婦科腫瘤（宮頸癌,、子宮內(nèi)膜癌等）等的放射治療。
研究方向：泌尿系統(tǒng)腫瘤和婦科腫瘤的綜合治療,。
主要教育和工作經(jīng)歷：
2008.07~2011.07 中山大學(xué)腫瘤防治中心 放療科 住院醫(yī)師
2011.07 ~2017.12 中山大學(xué)附屬第一醫(yī)院 放療科 主治醫(yī)師
2017.12~至今 中山大學(xué)附屬第一醫(yī)院 放療科 副主任醫(yī)師
社會(huì)兼職：
廣東省臨床醫(yī)學(xué)學(xué)會(huì)腫瘤學(xué)專業(yè)委員會(huì)常務(wù)委員,，
廣東省基層醫(yī)藥學(xué)會(huì)腫瘤多學(xué)科綜合診治專業(yè)委員會(huì)常務(wù)委員。
專著：
以第一（共一）,、通信（共同通信）作者在國(guó)內(nèi)外學(xué)術(shù)期刊發(fā)表論文19 篇,，參與及主持多項(xiàng)國(guó)家自然科學(xué)基金、省科技計(jì)劃,、廳局級(jí)科研項(xiàng)目,。
目前承擔(dān)\參加科研項(xiàng)目情況：
1. 吉西他濱（GEM）激活EB 病毒裂解性復(fù)制的分子機(jī)制研究、廣東省醫(yī)學(xué)科學(xué)技術(shù)研究基金項(xiàng)目
2. DNA-PKcs 基因敲除及其抑制劑影響DNA 雙鏈斷裂非同源重組末端連接修復(fù)的研究,、國(guó)自然基金委
主要論著(第一/共一/通訊)：
(1) YuFeng Ren, YuanHong Gao, XinPing Cao,et al., 3D-CT implanted interstitial brachytherapy for T2b NPC. Radiation Oncology 2010, 5:113
(2) YuFeng Ren, Yanfang Li, Jihong Liu. A modified shorten administration schedule for neoadjuvant chemotherapy with irinotecan and cisplatin in locally advanced cervical cancer. Int J Gynecol Cancer 2011;21: 685-689
(3) YuFeng Ren, XinPing Cao, Jia Xu,et al.,3D-image-guided high-dose-rate intracavitary brachytherapy for salvage treatment of locally persistent NPC. Radiation Oncology 2013,8:165
(4) Yan Xiong, YuFeng Ren, Jia Xu, et al.,.Enhanced external counterpulsation inhibits endothelial apoptosis via modulation of BIRC2 and Apaf-1 genes in porcine hypercholesterolemia. Int J Cardiol 2013, 11: 033
(5) YuFeng Ren, QuanCheng Zhao, Hui Liu,et al.,3D-image-guided HDR-BT versus 2D HDR-BT after external beam radiotherapy for early T-stage NPC.BMC Cancer.2014, 14:894
(6) Jia Xu, YuFeng Ren, Xue Xu,et al., Schistosoma japonicum tegumental protein 20.8role in reproduction through its calcium binding ability. Parasitol Res,2014,113:491–497
(7) Sangang Wu, Juan Zhou, YuFeng Ren,et al., Tumor location is a prognostic factor for survival of Chinese women with T1-2N0M0 breast cancer. International Journal of Surgery 2014,12:394
(8) YuFeng Ren, Huizhi Qiu, Yujie Yuan, ,et al.,Evaluation of 7th Edition of AJCC Staging System for Nasopharyngeal Carcinoma.Journal of Cancer.2017,8(9):1665
(9) Jinning Ye, Yufeng Ren, Jianhui Chen,et al., Prognostic Significance of Preoperative and Postoperative Complement C3 Depletion in Gastric Cancer: A Three-Year Survival Investigation. BioMed Research International. 2017(2)14.
(10) Li Ma, Guang, Yu Luo, YuFeng Ren, ,et al.,Concurrent chemoradiotherapy combined with enteral nutrition support: a radical treatment strategy for esophageal squamous cell carcinoma patients with malignant fistulae.CJC.(2017) 36:8
(11) Shaoqing Niu, Ge Wen, Yufeng Ren,et al., Predictive Value of Primary TumorSite for LocoregionalRecurrence in Early Breast Cancer Patients with One toThree Positive Axillary Lymphadenophy. Journal of Cancer 2017,(4).8
(12) Jun D,Tian Z,Yufeng Ren,et al.,Inhibiting DNA-PKcs in a non-homologus end-joining pathway in response to DNA double-strand breaks.Oncotarget.2017.07.
(13) Ren,YF;Ye,JN;Zhang,J,et al.,Adjuvant radiation therapy for positive lymph nodes after resection of esophageal squamous cell carcinoma: Can it earn promising benefits within long-term follow-up?Annals of Oncology.(Abstract).2017:28:3:P-066
(14) Ye,JN; Ren,YF; Wang,Y,et al.,The optimal application of transrectal ultrasound in staging of rectal cancer following neoadjuvant therapy: A pragmatic study for accuracy investigation. Annals of Oncology.(Abstract).2017(28):3: P-365
(15) Y.Ren,J.Ye,W.Xiong,J,et al., Adjuvant radiotherapy for positive lymph nodes of oesophageal squamous cell carcinoma:can it earn promising benefits at long-term follow-up? Cancer Radiother, 2018:1278.
(16) Yufeng Ren,Jinning Ye,Yan Wang,et al.,The Optimal Application of Transrectal Ultrasound in Staging of Rectal Cancer Following Neoadjuvant Therapy: A Pragmatic Study for Accuracy Investigation. Journal of Cancer 2018 (9)
(17) Jinning Ye, Yufeng Ren, Zhewei Wei,et al., External validation of a modified 8th AJCC TNM system for advanced gastric cancer: Long-term results in southern China. Surgical Oncology 27 (2018) 146-153.
(18) Jun Dong, Yufeng Ren , Tian Zhang,,et al., Inactivation of DNA-PK by knockdown DNA-PKcs or NU7441 impairs non-homologous end-joining of radiation-induced double strand break repair. ONCOLOGY REPORTS,2018 39: 912
(19) Yujie Yuan, Jinning Ye, Yufeng Ren.Exploration of the optimal treatment regimes for Esthesioneuroblastoma: a single center experience in China. Journal of Cancer.2018;9(1): 174
